ShRNA-mediated stable knockdown of p32 in glioma cell lines and patient-derived tumor initiating cells impaired cell proliferation in vitro and tumorigenic potential in vivo in xenograft mouse models. This evidence concerns the gene C1QBP and neoplasm.